Profilo
Daniel J.
Estes is currently Director at Semnur, Inc., Cirius Therapeutics, Inc. (Independent Director since 2017), Lengo Therapeutics, Inc., Inipharm, Inc., Radionetics Oncology, Inc., and General Partner at Frazier Management LLC since 2020.
Former positions include Independent Director at Sierra Oncology, Inc. from 2017 to 2019, Independent Director at Arcutis Biotherapeutics, Inc. from 2017 to 2020, Director at Outpost Medicine, Inc., Director at Sudo Biosciences, Inc., Consultant at McKinsey & Co., Inc. in 2011, Research Assistant at Stanford University in 2003, and Researcher at the University of Michigan from 2004 to 2008.
Education includes an undergraduate degree from Stanford University conferred in 2003 and a doctorate from the University of Michigan conferred in 2008.
Posizioni attive di Daniel Estes
| Società | Posizione | Inizio |
|---|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Investitore di Private Equity | 01/04/2011 |
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Direttore/Membro del Consiglio | - |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Direttore/Membro del Consiglio | 01/03/2017 |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Direttore/Membro del Consiglio | - |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Direttore/Membro del Consiglio | - |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Daniel Estes
| Società | Posizione | Fine |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2020 |
| SIERRA ONCOLOGY, INC. | Direttore/Membro del Consiglio | 22/11/2019 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 31/03/2011 |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Daniel Estes
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Semnur, Inc.
Semnur, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and commercializes non-opioid pain therapies | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in drug development activities | Health Technology |
Cirius Therapeutics, Inc.
Cirius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company that develops therapies | Health Technology |
Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Lengo Therapeutics, Inc.
Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops small molecule precision therapeutics that target driver mutations in oncology | Health Technology |
Inipharm, Inc.
Inipharm, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that develops therapies for liver and related diseases | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Radionetics Oncology, Inc.
Radionetics Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that discovers and develops novel radio therapeutics for the treatment of oncology indications | Health Technology |
















